Quick Answer
Zura Bio Ltd reported Stockholders Equity of $101.54 million for fiscal year 2025.
Zura Bio Ltd Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $101.54M | -30.8% |
| 2024 | $146.81M | +147.5% |
| 2023 | $59.33M | +285.1% |
| 2022 | -$32.06M | -249.2% |
| 2021 | -$9.18M | — |
| 2021 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $108.24M | -29.3% | -14.0% |
| June 30, 2025 | $125.91M | -19.6% | -8.9% |
| March 31, 2025 | $138.20M | +126.5% | -5.9% |
| December 31, 2024 | $146.81M | +147.5% | -4.1% |
| September 30, 2024 | $153.05M | +142.1% | -2.2% |
| June 30, 2024 | $156.52M | +127.1% | +156.6% |
| March 31, 2024 | $61.01M | +119.0% | +2.8% |
| December 31, 2023 | $59.33M | +285.1% | -6.1% |
- Zura Bio Ltd showed a decrease of -30.8% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from Zura Bio Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: